Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-30

Clinical Trial Update: Liposomal Bupivacaine for Pain Control After Total Shoulder Arthroplasty [NA]

View source ↗

Summary

Completed clinical trial evaluating liposomal bupivacaine for pain control after shoulder arthroplasty; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Johns Hopkins University | Conditions: Osteoarthritis, Arthropathy | NA | Status: COMPLETED | Results posted: 2020-03-30